Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Richard Fux"'
Autor:
Stephan C. Bischoff, Julia Nachbar, Richard Fux, Reinhild Trapp, Karen Schmidt, Michael Viapiano
Publikováno v:
Aktuelle Ernährungsmedizin. 47:289-308
ZusammenfassungDie Durchführung der parenteralen Ernährung im ambulanten Bereich wird durch zahlreiche Verunsicherungen behindert. Der niedergelassene Arzt ist nicht selten unzureichend vertraut mit der komplexen Materie und wendet sich an die Vero
Autor:
Reinhild Bücheler, Christoph Meisner, Ruth Bösel, Richard Fux, Christine Jägle, Lusine Danielyan, Katrin Schwarz, Christoph H. Gleiter, Klaus Mörike
Publikováno v:
Acta Medico-Biotechnica. 2:31-44
Purpose: Our aims were to determine the prevalence of physicians’ adherence to antithrombotic guidelines in the management of outpatients with chronic atrial fibrillation (AF) and to identify risk factors for nonadherence to treatment guidelines. M
Publikováno v:
Journal of Chromatography B. 828:122-125
A modification of the Bio-Rad® total homocysteine HPLC-test is presented in order to enable not only plasma homocysteine measurements but also the quantification of homocysteine in urine samples using the same principle of measurement. Coelution of
Impact of genotype on adverse effects during treatment with metoprolol: A prospective clinical study
Autor:
Ursula Delabar, Anne M.T. Pröhmer, Richard Fux, Gernot Lorenz, Elke Schaeffeler, Christoph H. Gleiter, Michel Eichelbaum, Kari T. Kivistö, Klaus Mörike, Matthias Schwab
Publikováno v:
Clinical Pharmacology & Therapeutics. 78:378-387
Objective Our objective was to study the impact of the cytochrome P450 (CYP) 2D6 polymorphism on the tolerability of metoprolol in a real-life primary care setting. The adverse effects studied comprised effects related to the central nervous system,
Publikováno v:
Clinical Cancer Research. 11:4754-4760
Purpose: Cyclooxygenase-2 (COX-2) expression in human colorectal cancer and adenoma tissue seems to be higher than in normal mucosa. However, data about the relation between COX-2 expression and patient survival are inconclusive as yet. Therefore, we
Autor:
Richard Fux, Klaus Mörike, T.D. Bethke, Gabriele M. Böhmer, Christoph H. Gleiter, Dietrich Knoerzer, Wilhelm Wurst, Robert Hermann, Michael David, Bernhard Hauns
Publikováno v:
Journal of clinical pharmacology. 47(1)
The dose-proportional, intraindividual, single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor under investigation for chronic obstructive pulmonary disease and asthma, was investigated in healthy
Autor:
Richard, Fux, Klaus, Mörike, Anne M T, Pröhmer, Ursula, Delabar, Matthias, Schwab, Elke, Schaeffeler, Gernot, Lorenz, Christoph H, Gleiter, Michel, Eichelbaum, Kari T, Kivistö
Publikováno v:
Clinical pharmacology and therapeutics. 78(4)
Our objective was to study the impact of the cytochrome P450 (CYP) 2D6 polymorphism on the tolerability of metoprolol in a real-life primary care setting. The adverse effects studied comprised effects related to the central nervous system, cardiovasc
Autor:
Richard, Fux, Christoph, Meisner, Matthias, Schwab, Gernot, Lorenz, Klaus, Mörike, Christoph H, Gleiter
Publikováno v:
Zeitschrift fur arztliche Fortbildung und Qualitatssicherung. 98(8)
Metoprolol has not yet been systematically studied in terms of quality of life and incidence of adverse drug reactions (ADRs). Metoprolol is metabolized by polymorphic CYP2D6, therefore poor CYP2D6 metabolizers may be at higher risk of ADRs. Therefor
Publikováno v:
The Annals of pharmacotherapy. 38(2)
OBJECTIVE To report a case of ginger–phenprocoumon interaction resulting in an elevated international normalized ratio (INR) and epistaxis. CASE SUMMARY A 76-year-old white European woman on long-term phenprocoumon therapy with an INR within the th
Autor:
Reinhild, Bücheler, Christoph, Meisner, Klaus, Mörike, Richard, Fux, Kirsten, Hauswald, Gernot, Lorenz, Volker, Kühlkamp, Christoph H, Gleiter
Publikováno v:
Zeitschrift fur arztliche Fortbildung und Qualitatssicherung. 97(6)
Large randomised studies have definitely shown that oral anticoagulation effectively reduces thromboembolic complications, e.g. stroke, in patients with chronic non-valvular atrial fibrillation (AFib). However, less than 50% of the eligible AFib pati